In patients with mild multi-infarct dementia, cerebrolysin significantly improved memory.
In plain wordsIn patients with mild multi-infarct dementia, cerebrolysin improved memory.
- Peptide
- Cerebrolysin
- Outcome
- IncreaseMemory
- Study
n = 60
- Comparator
- Placebo (same volume of 0.85% NaCl solution)
- Outcome group
- Cognition and memory · Nervous system and cognition
- Studied dose
- 15 ml daily (10 ml in the morning and 5 ml in the evening) · intravenous · 28 daysAs given in this study (human).
Source sentences
The study found a significant improvement of the memory (p-0.01), abstract thinking and time of reaction in the patients on cerebrolysin, confirmed also by the EEG-mapping.
3 context sentences(design, population, supporting numbers)
The randomized double-blind placebo-controlled study of the effectiveness of cerebrolysin in a mild form of multi-infarct dementia was carried out.
Sixty patients were divided in two equal groups differing significantly at the beginning of the study by none of the compared parameters.
They received for 28 days daily drop intravenous doses of cerebrolysin (15 ml of the drug in 200 ml of a 0.85% NaCl solution: 10 ml in the morning and 5 ml in the evening) or placebo in the same amount of the solution.